576. Which test to use to measure the anticoagulant effect of rivaroxaban the prothrombin 579. Which test to use measure the anticoagulant effect of rivaroxaban 581. Weibel palade bodies a window…
327 Response variability to clopidogrel is tailored treatment based on laboratory testing the right solution 337 Exogenous activated protein C inhibits the progression of diabetic nephropathy 34…
985 safety of catheter delivered plasmin in patients with acute lower extremity arterial or bypass graft occlusion 992 Sex hormone-binding globulin as a marker for the thrombotic risk of hormonal …
1207. The impact of blood coagulabillity on atherosclerosis and cardiovascular disease 1217. Aspirin twice a day keeps new COX-1 at bay 1220. The recovery of platelet cyclooxygenase activity expl…
1 Mechanisms and clinical implications of thrombosis in paroxysmal nocturnal hemoglobinuria 11 Isolated distal deep vein thrombosis what we know and what we are doing 20 Reduced cardiovascular m…
167 Novel roles of cAMP/cGMP dependent signaling in platelets 177 Megakarycocytes malignancy and bone marrow vascular 189 Comparison of associations of adherence to a dietary approaches to stop h…
1. VKORC1 molecular target of coumarins 7 Type 1 von willebrand disease 12 In vivo thrombus formation 18 Mechanics of proplatet elaboration 24 Fibrin and fibrinolysis in infection and host defense
1 Fibrinogen concentrate for management of bleeding 6 Fibrinogen concentrate for management of bleeding against indiscriminate use 9 Factor XIII novel strutcural and functional aspects 21 Bewar…
2. Gene therapy for haemophilia a long and winding road 12. recent progress in anticoagulant therapy oral direct inhibitors of thrombin and factor Xa 20 Molecular mechanism of inside out integri…
893. Efficiacy and safety of anticoagulants in the prevention of venous thromboembolism in patients with acute cerebral hemorrhage a meta analysis of controlled studies 899. Genetic determinants o…